Cross-sectional study of the association of abomasal displacement or volvulus with serum electrolyte and mineral concentrations in dairy cows

The objective of this study was to evaluate serum mineral and electrolyte concentrations at the time of on-farm diagnosis of left displaced abomasum, right displaced abomasum, or abomasal volvulus in dairy cows. Data were collected from 104 affected cows and 96 control cows matched with cases, based on herd, parity, and stage of lactation. Cows with abomasal displacement or volvulus had significantly lower calcium, phosphorous, magnesium, potassium, and chloride concentrations and increased anion gap at the time of diagnosis compared with control cows from the same herds. The percentages of cases and controls with total serum calcium concentrations below the lower limit of the laboratory reference range (2.08 mmol/L [8.3 mg/dL]) were 70% and 23%, respectively. Based on the large percentage of cases with hypocalcemia, administering calcium salts at the time of treatment of field cases of abomasal displacement or volvulus may be beneficial.     

丝氨酸蛋白抑制剂与围产期奶牛血钙的关系

本研究旨在了解围产期低血钙奶牛与正常奶牛的血浆Serine peptidase inhibitor(SERPIN)与血钙之间的关系。在分娩当天、产前14～7d和产后7～14d根据血钙浓度将实验牛分为正常对照组(2.20～3.5mmol/L,C)和低血钙组(<2.20mmol/L,T),每组3头。利用Westernblotting检测试验牛血浆SERPIN丰度。结果显示:SPI蛋白在奶牛发生低血钙时,表达上调。结论:本试验首次证明了血浆SERPIN与血钙浓度呈负关联,血钙可能通过SERPIN途径调节机体的凝血过程和免疫功能。     

An investigation of the safety of oral calcium formate in dairy cows using clinical, biochemical and histopathological parameters

AIM: To investigate the safety of orally administered calcium formate in dairy cows fed adequate amounts of good quality pasture. METHODS: Twelve mixed-age pasture-fed lactating dairy cows were randomly allocated to three groups (n=4 cows/ group). Group 1 served as untreated controls. Group 2 was treated orally with 400 ml of 13.4% (w/w) calcium as calcium chloride gel, four times at approximately 12-h intervals. Group 3 was treated orally with 350 ml of 11.4 % (w/w) calcium as a 48.6% aqueous suspension of calcium formate, four times at approximately 12-h intervals. Cows grazed good quality autumn ryegrass and white clover pasture throughout the trial. All cows were examined clinically each evening and a blood sample collected. Cows were slaughtered 75 h after the last treatment and viscera examined visually for lesions. Samples from the mid-fundic area of the abomasum of each cow were collected for histopathological examination. Blood samples collected pre and 90-h post-first treatment were analysed for serum haptoglobin and pepsinogen concentrations. RESULTS: No evidence of abnormality was detected by observation or clinical examination in any of the trial cows. Serum haptoglobin concentrations were basal for all groups pre-treatment and remained basal for Groups 1 and 3 post-treatment, but were elevated post-treatment for Group 2 (p=0.016). No differences in serum pepsinogen concentrations were detected between sampling times or treatment groups. One cow from Group 2 had several small (5 mm) abomasal ulcers present at necropsy. Another cow from the same group had histopathology suggestive of thrombosis and re-endothelialisation. CONCLUSIONS: Oral administration of calcium formate (350 ml of 48.6% aqueous suspension) administered on four occasions at 12-h intervals had no adverse effects on the four cows examined, and as such is considered a safe form of calcium supplementation in adult dairy cows.     

Effects of low and high calcium intake prepartum on calcium mobilization rate around parturition in dairy cows

Forty-one dairy cows were fed a low (LCa-13 g/d) and a high (HCa-83.5 g/d) calcium ration in the 8 weeks prior to parturition and the effect on the Ca mobilization rate around parturition was studied. Plasma Ca values were stable in the LCa group around parturition. In the older cows of the HCa group a very slight decrease in the mean plasma Ca was observed: 2.58 mmol/l at 12-36 h ante partum decreased to 2.38 mmol/l at parturition. Hypocalcaemia, which commonly occurs around parturition, did not occur in 40 of the cows. A subclinical hypocalcaemia (1.8 mmol/l) occurred in one cow (parity 10) from the HCa group. To assess the efficiency of Ca mobilization, a severe hypocalcaemia (1.0 mmol/l) with clinical signs was induced by means of Na2EDTA infusion (0.90 mmol/min), starting at 10 h post-partum. The older cows in the LCa group required more Na2EDTA than those in the HCa group. Higher urinary hydroxyproline excretion in the week before parturition in the LCa than in the HCa group suggested a higher bone turnover. Plasma PTH levels around parturition were not significantly different between the groups. The amount of colostrum milked out in the first 10 h post-partum did not influence Ca homeostasis around parturition. The results contradict those of many other experiments in which hypocalcaemia was observed in cows ingesting high levels of Ca. It is concluded that the restricted feed intake prepartum possibly had a favourable effect on Ca homeostasis.     

Milk fever and alert downer cows: does hypophosphatemia affect the treatment response?

The purpose of this prospective cohort study was to identify factors that place a dairy cow with uncomplicated milk fever (MF) at significant risk of becoming an alert downer cow (ADC) and to verify if these factors could be used to predict treatment outcome. Recumbent MF cows were examined before treatment and 52 were excluded due to complications. In all, histories and pretreatment serum samples were taken and the serum of 86 cows was analyzed for electrolyte levels (calcium, phosphorus, magnesium, and potassium). In total, 36 of the 86 samples were from ADCs and 50 from animals that responded to MF treatment (MFT). A binary-two-factor logistic model determined that a MF cow with a phosphorus pretreatment level of > or = 0.9 mmol/L was 12 times more likely not to become an ADC than one with a phosphorus level < 0.9 mmol/L (CI: 6.3,23.1). Also, a binary multivariable logistic regression analysis showed that a MF cow with a pretreatment calcium level > or = 1.7 mmol/L was 14 times more likely to become an ADC than one with a serum level < 1.7 mmol/L (CI: 2.0,98). Age and the other serum electrolytes were not statistically significant risk factors at the 0.05 level. The rigorous pretreatment examination and stringent adherence to protocol reduced ADC misclassification and fostered the strong association between single factor serum phosphorus levels and ADCs. By using a cutoff level of serum phosphorus at > or = 0.9 mmol/L, a practitioner could correctly predict that 95% of the MFs would not become ADCs and, therefore, this level would be a useful pretreatment predictor.     

Relationship between blood calcium level and ST peak interval of electrocardiographic variables in peripartum Holstein cows

The association between blood calcium levels and electrocardiographic variables was compared in 137 normal parturient and 36 peripartum recumbent Holstein cows to determine whether hypocalcemia in peripartum dairy cows can be rapidly diagnosed using electrocardiograph. Inverse of STc (ST peak interval/SS interval^0.5) and blood ionized calcium or serum calcium concentrations were strongly correlated, and both correlation coefficients were 0.81 (P<0.001). The 95% prediction interval indicated that cows with STc >0.385 ± 0.001 sec are very likely to be hypocalcemic (blood ionized or serum calcium concentrations of <0.9 mmol/l or <7.5 mg/dl, respectively). These findings indicate that hypocalcemia in parturient cows can be non-invasively estimated using the STc.     

围产期奶牛血钙影响因素及其与生产性能关系分析

本试验旨在探究围产期奶牛血钙浓度影响因素及其与生产性能的关系。于2018年7月20日—8月15日对北京地区36头围产期健康荷斯坦牛的血钙浓度进行测定,收集该牛场奶牛生产性能测定(DHI)报告,利用固定效应模型分析不同胎次、体况评分(BCS)、健康状况及血钙浓度变异度对血钙浓度的影响。结果表明:血钙浓度与产后天数存在显著的正向相关关系;经产牛的血钙浓度(1.40 mmol/L)极显著高于初产牛(1.31 mmol/L);不同BCS分组奶牛血钙浓度差异不显著;健康组的血钙浓度(1.41 mmol/L)显著高于患病组(1.30 mmol/L);血钙浓度变异度的大小影响奶牛的产奶量,初产奶牛低变异度组的产奶量(16.70 kg/d)显著高于中变异度组(9.75 kg/d)和高变异度组(5.63 kg/d)。本研究进一步揭示了围产期荷斯坦牛血钙浓度的变化规律以及其影响因素,为预防奶牛产后低血钙症的发生以及制定提高奶牛生产性能的饲养管理策略提供参考。     

Influence of prepartum calcium intake on calcium mobilization rate around parturition in dairy cows fed at a high prepartum feeding level

The influence of a low and a high prepartum calcium (Ca) intake on Ca mobilization rate around parturition was studied in 44 dairy cows fed a ration sufficient for 1.90 times maintenance requirements during the dry period. The plasma Ca level declined on the day of parturition in the group fed the low Ca intake (LCa: 26.4 g/d) as well as in the group fed the high Ca intake (HCa: 87.2 g/d). Plasma Ca levels of the HCa group were lower at parturition, and in this group 1 cow had milk fever after parturition. In the HCa group 6 cows had a plasma Ca level less than or equal to 2.0 mmol/l at parturition and/or 10 h post-partum (pp), versus 1 cow in the LCa group. Na2EDTA was intravenously infused at 10 h pp to induce hypocalcaemia to a level of plasma Ca not bound to EDTA of approximately 1.0 mmol/l. The LCa groups tended to require more Na2EDTA than the HCa groups, however the difference was significant only in the younger cows. After the Na2EDTA infusion 7 cows of the HCa group and 1 of the LCa group did not recover spontaneously and needed to be treated. The mean plasma PTH levels of the LCa group ante-partum were slightly higher than those of the HCa group. The Ca level of the prepartum ration did not influence urinary hydroxyproline excretion, which suggests that the Ca intake of 26.4 g/d was too high to stimulate bone turnover. Comparison of the present results with those of an earlier experiment in which the prepartum Ca intake at a low feeding level (1.12 times maintenance) was studied, led to the conclusion that higher prepartum feed intake has a clear negative influence on Ca homeostasis around parturition.     

Serum ionized calcium concentration in clinically normal dairy cattle, and changes associated with calcium abnormalities

Serum ionized calcium (ICa) concentration was determined in 141 clinically normal dairy cattle by use of a direct-measuring calcium ion-selective electrode instrument. Mean serum ICa concentration 2 hours after blood withdrawal was 4.59 mg/dl; range varied from 3.79 to 5.25 mg/dl. Regression analysis indicated a high degree of correlation between ICa and serum total calcium concentrations if serum stored at 23 C was analyzed within 12 hours after blood withdrawal. Abnormal ICa concentration was detected in 19 of 85 dairy cows that were affected with various pathologic conditions. All 19 cows had hypocalcemia (n = 13 with parturient hypocalcemia, 4 with hypomagnesemic tetany, and 2 with renal disease). In all cases, the ICa concentration clearly related to the clinical manifestation of disease and the functional status of the cow's calcium metabolism.     

Concentrations of metabolites and hormones in the blood plasma of lactating dairy cows during treatment with recombinant bovine somatotropin (BST)]

Sixteen lactating dairy cows were submitted to six injections in a four-week interval of either 640 mg prolonged release bST or of 640 mg saline (control, n = 8). The bST-treated animals were pair fed to the control cows, which were fed according to requirements. Fourteen days after each injection, blood samples were derived and analysed for metabolites and hormones. Plasma contents averaged 0.16 mmol/l non esterified fatty acids (NEFA), 2.69 mmol/l glucose, 0.43 mmol/l beta-hydroxybutyrate, 0.024 mmol/l acetoacetate, 78.8 g/l protein, 4.6 mmol/l urea, 0.81 micrograms/l insulin, 44.4 ng/l thyroxine (T4) and 1.41 ng/l triiodothyronine (T3). The bST-application was without effect on the analysed plasma contents.     

Efficacy of ceftiofur hydrochloride sterile suspension administered parenterally for the treatment of acute postpartum metritis in dairy cows

OBJECTIVE: To evaluate the efficacy of ceftiofur hydrochloride sterile suspension administered parenterally for treatment of acute postpartum metritis (APM) in dairy cows. DESIGN: Multilocation, randomized block, field trial. ANIMALS: 406 cows in the first 14 days postpartum. PROCEDURE: Cows with rectal temperatures > or = 39.5 degrees C (103.1 degrees F) without clinical signs of respiratory or gastrointestinal tract disease and with a fetid vaginal discharge were allocated randomly in blocks of 3 to 3 treatment groups: sterile saline (0.9% NaCl) solution administered at a dosage of 2 mL/45.4 kg (2 mL/100 lb), SC or IM, once daily for 5 days (control); or ceftiofur hydrochloride administered at a dosage of 1.1 or 2.2 mg of ceftiofur equivalents (CE)/kg (0.5 or 1 mg/lb, respectively), SC or IM, once daily for 5 days. Cows were evaluated on days 6, 10, and 14, and clinical cure or failure to cure was determined. Clinical cure was defined as no additional antimicrobial treatment administered, rectal temperature < 39.5 degrees C, and absence of a fetid vaginal discharge. RESULTS: On day 14, clinical cure rates were 77%, 65%, and 62% for the 2.2 mg of CE/kg, 1.1 mg of CE/kg, and control groups, respectively. No significant differences were detected in clinical cure rates between control and treatment groups on day 10 or 6. CONCLUSIONS AND CLINICAL RELEVANCE: Ceftiofur hydrochloride administered at a dosage of 2.2 mg of CE/kg, SC or IM, once daily for 5 days was efficacious for treatment of APM in dairy cows.     

Blood chemistry values of juvenile red pacu (Piaractus brachypomus)

Abstract: Blood samples were collected from 29 juvenile red pacu ( Piaractus brachypomus ), ornamental freshwater fish, to establish baseline blood chemistry values. Mean (minimum-maximum) values, obtained by automated bichromatic analysis and ion selective electrode analysis, were as follows: sodium, 150.4 (146–159) mmol/L; potassium, 3.93 (2.7–5.0) mmol/L; chloride, 138.7 (128–150) mmol/L; total CO₂, 7.5 (6–10) mmol/L; albumin, 0.86 (0.5–1.0) g/dL; lactate dehydrogenase, 237.8 (65–692) IU/L; aspartate aminotransferase, 49.1 (0–125) IU/L; creatinine, 0.31 (0.2–0.4) mg/dL; calcium, 10.80 (9.5–12.5) mg/dL; anion gap, 6.89 (1.2–12.5) mmol/L; and phosphorus, 7.29 (4.1–8.9) mg/dL.     

Management practices associated with udder health of first-parity dairy cows in early lactation

This study aimed at investigating associations between management routines including feeding, housing, and milking around calving, and udder health of first-parity cows in early lactation in Swedish large, high producing, low bulk-milk somatic cell count (SCC) dairy herds housed in free stalls. Seventy-two dairy herds participated and data concerning 1189 first-parity cows calving during the study period (October 2005-January 2006) was collected. Multivariable regression analysis were performed with three different outcomes; within-herd number of first-parity cows veterinary treated for clinical mastitis at days -10 to 60 after calving, within-herd number of first-parity cows with a SCC> or =200,000cells/mL at first test-day, and SCC of first-parity cows at first test-day. Cow factors significantly associated with good udder health of first-parity cows (few cases of clinical mastitis and or low SCC) were being of the Swedish Red breed, having a high milk yield at first test-day, and a milk-urea > or =5mmol/L at first test-day. Herd factors significantly associated with good udder health were having mattresses as flooring in the cubicles in the lactating cow housing, and to house the first-parity cows in tie stalls 1 month before calving. Cow factors significantly associated with poor udder health of first-parity cows were having a milk-urea <4mmol/L at first test-day. Herd factors significantly associated with poor udder health of first-parity cows were feeding first-parity cows sugar-beet pulp or corn silage, and to give silage from a different batch to pregnant heifers than to lactating cows. Moreover, to have sawdust or shavings in the calving pen, to be moved from the calving pen > or =2 days after calving, to milk first-parity cows at the calving site instead of in the parlor, and to rinse, clean or disinfect milking units before a first-parity cow was milked were also significantly associated with poor udder health of first-parity cows. The results indicate that different control measures must be taken depending on the nature of the udder health problem.     

Responses in milk production to the control of gastrointestinal nematode and paramphistome parasites in dairy cattle

Objective To determine the effect of treating naturally acquired gastrointestinal nematode and paramphistome infections on milk production in dairy cattle.
Design A field trial.
Animals One thousand two hundred and thirty nine dairy cows.
Procedure Cows were either not treated or treated with 4.5 mg/kg oxfendazole, 16.6 mg/kg oxyclozanide or 4.5 mg/kg oxfendazole and 16.6 mg/kg oxyclozanide in March, May and August.
Results A significant increase in milk production, averaging 0.4 L (SE 0.2) per day, was seen when dairy cows infected with gastrointestinal nematodes and paramphistomes were treated with oxfendazole or oxfendazole and oxyclozanide in March, May and August. Cows treated with oxyclozanide alone at these times produced no more milk than untreated cows.
Faecal egg counts confirmed that oxyclozanide treatment reduced paramphistome populations and oxfendazole treatment reduced nematode populations in cows over the 7-month monitoring period.
Conclusion When dairy cows infested with gastrointestinal nematodes and paramphistomes were treated with oxfendazole alone or oxfendazole and oxyclozanide in March, May and August milk production increased.     

A survey of the phosphorus and calcium contents of pastures and the serum inorganic phosphorus and calcium contents of cows on four Manawatu dairy farms

Serum inorganic phosphorus (Pi) and calcium (Ca) concentrations were assessed in 20 cows on each of four Manawatu factory supply dairy farms. Blood was taken from each cow before calving and at six-week intervals during lactation. Bleeding coincided with herd testing. Herds of Friesian or Friesian X cows and Jersey or Jersey X cows were compared on adjacent farms on a Central Yellow-brown Sand and on adjacent farms on a Peat Loam overlying a Central Yellow-brown Earth soil. Pasture mass and composition were estimated to grazing height in the next two paddocks to be grazed in the rotation. Mean serum Pi concentration was higher in cows on sandy soils (1.55 mmol Pi/l than in cows on the peat loam (1.34 mmol Pi/l (P<0.001). Concentrations were highest before calving (1.69 mmol Pi/l) but fell to low levels at peak lactation (1.17mmol Pi/l when 70% of cows were below the minima of the 'normal range', and during the drought (1.29 mmol Pi/l. Pasture phosphorus (P) concentrations were adequate to support cow nutrition for lactation (>0.33% DM, ad lib. feeding) until the summer drought when low herbage mass would have restricted milk production. Serum Ca was adequate for lactating cows and changed little between months or between cows (mean 2.12 mmol Ca/l). No metabolic disorders relating to mineral deficiencies were observed. It appears that serum Pi in a high proportion of cows falls below the normal range during peak lactation without cows displaying clinical deficiency symptoms or a depression in butterfat production.     

Characterization of the serum metabolic profile of dairy cows with milk fever using 1H-NMR spectroscopy

Background: Milk fever (MF) is a common calcium metabolism disorder in perinatal cows. Currently, information regarding the detailed metabolism in cows suffering from MF is scant.

Objective: The purpose was to study the metabolic profiling of serum samples from cows with MF in comparison to control cows, and thereby exploring other underlying pathological mechanisms of this disease.

Animals and methods: In the current study, we compared the serum metabolomic profile of dairy cows with MF (n = 8) to that of healthy dairy cows (n = 24) using a 500-MHz digital ¹H-nuclear magnetic resonance (¹H-NMR) spectrometer. Based on their clinical presentation and serum calcium concentration, cows were assigned either to the control group (no MF symptoms and serum calcium concentration >2.5 mmol/L) or to the MF group (MF symptoms and serum calcium concentration <1.4 mmol/L). For statistical analysis, a one-way analysis of variance was performed.

Results: We identified differences regarding nine metabolites between the two groups, among which glucose, alanine, glycerol, phosphocreatine, and gamma-aminobutyrate decreased, and β-hydroxybutyrate, acetone, pyruvate, and lysine increased in cows with MF. Most of these were carbohydrates and amino acids involved in various energy metabolism pathways.

Conclusion: The different metabolites in cows with MF reflected the pathological features of negative energy balance and fat mobilization, suggesting that MF is associated with altered energy metabolism.

Clinical importance: The ¹H-NMR spectroscopy can be used to understand the pathogenesis of MF and identify biomarkers of the disease.     

The effects of calcium supplementation of dairy cattle after calving on milk, milk fat and protein production, and fertility

AIM: To determine the effect of calcium supplementation of dairy cattle after calving on serum concentrations of calcium, magnesium, and phosphorous after calving, and on reproductive and productive performance in the following lactation. METHODS: This was a double-blind randomised clinical trial using 356 dairy cows of parity 3 or greater from six seasonally calving commercial dairy herds. Cows were randomly assigned to a treatment and control group. The treatment group received two doses of 380 ml of calcium chloride in oil (49 g of elemental calcium); the first dose was given as soon as practical after calving and the second 12 hours later. Control cows received 380 ml of a placebo using the same treatment regime. Treatment and control cows had blood samples taken during the first 7 days after calving to determine serum calcium, magnesium and phosphorous levels. Treatment and control cows were monitored throughout the lactation to measure production and reproductive performance. RESULTS: Treatment had no effect on PSM to first service intervals. Treatment significantly reduced PSM to conception intervals in only one of the four herds with data available for analysis (p = 0.09). There was no difference between treatment groups for adjusted corrected milk yield calculated from the first herd test milk yield (p = 0.93) or 305-day milk solids production (p = 0.19). CONCLUSION: Further studies are required to identify reasons for the between-herd effectiveness of calcium chloride treatment in improving fertility.     

Incidence of subclinical ketosis in cows supplemented with a monensin controlled-release capsule in Holstein cattle, Florida, USA

The objective of this study was to determine the effect of a monensin controlled-release capsule on the proportion of cows with subclinical ketosis (SK). During July to August 2001, 300 cows dried-off 50-70 days before expected parturition were randomly assigned to either a treatment (n = 150, oral capsule, 335 mg/d of monesin for 95 d) or control group (no capsule, n = 150). At 14 days postpartum, a milk sample was obtained and evaluated for beta-hydroxybutyrate (BHBA) using a semi-quantitative ketone test strip. In a sub-sample of 50 cows per group a blood sample was taken and analyzed for BHBA using an ELISA kit. Milk BHBA > or = 200 micromol/L was used as the cut-off value for diagnosis of SK. The incidence of SK based on the milk test was statistically different between groups (P < or = 0.05) with a value of 26.6% for control and 14.5% for cows treated with monensin, respectively. Cows treated with monensin were 0.68 times less likely to give a positive result for milk BHBA than non-treated cows (0.53-0.80; 95% CI). Serum BHBA concentrations did not differ between groups (0.81 +/- 0.09 mmol/L versus 0.70 +/- 0.07 mmol/L for controls and treated, respectively; P > 0.05). However, for each incremental increase in serum BHBA of 0.1 mmol/L occurrence of SK increased 52% (OR = 1.52; 1.21-1.91; 95% CI).     

Presumptive increase in protein‐bound serum calcium in a dog with multiple myeloma

Abstract: An 11‐year‐old male castrated Australian Shepherd was presented with a history of lethargy, panting, and weight loss for 1 month. Physical examination revealed a moderately enlarged spleen. Laboratory abnormalities included thrombocytopenia and marked hypercalcemia, with hyperglobulinemia, hypoalbuminemia, and a monoclonal spike in the β‐globulin region on serum protein electrophoresis. Serum total calcium concentration was markedly increased (16.5 mg/dL, reference interval 8.9–11.4 mg/dL) but ionized calcium concentration (1.39 mmol/L) was within the reference interval (1.25–1.45 mmol/L). Isosthenuria was noted, but the dog was not polyuric or polydipsic. Serum parathyroid hormone concentration was within reference limits and parathyroid hormone‐related peptide concentration was 0 pmol/L. Radiographic findings were largely unremarkable. Results of cytologic evaluation of a fine‐needle aspirate specimen from the spleen indicated plasma cell neoplasia. Based on the results of the electrophoresis, splenic aspirates, radiographs, and hypercalcemia, a diagnosis of splenic multiple myeloma was made. The marked hypercalcemia, normal ionized calcium and parathyroid hormone concentrations, and lack of osteolytic lesions indicated a presumptive increase in protein‐bound serum calcium, likely due to binding to molecules of the paraprotein (M protein). Protein binding of calcium in dogs with multiple myeloma should be considered as a potential mechanism of elevated total serum calcium concentration.     

Efficacy of controlled-release capsules containing monensin for the prevention of subclinical ketosis in pasture-fed dairy cows

AIMS: To determine the effectiveness of intra-rumenal controlled release capsules (CRC) containing 32?g of monensin administered pre-calving to reduce the cumulative incidence of subclinical ketosis (SCK) in mainly pasture-fed dairy cows.

METHODS: Cows (n=837) due to calve in the first 6 weeks of the spring calving period were enrolled from four commercial herds in the Waikato region of New Zealand in a blinded, randomised, negative-controlled field trial. Three weeks before the start of the calving period cows were randomly allocated to receive either no treatment (control) or a single CRC containing monensin and then blood sampled on two occasions, 7 days apart within 12 days following calving for measurement of concentrations of beta hydroxybutyrate (BHBA) in blood. Cows were diagnosed with SCK if the concentration of BHBA in blood in either of these samples was ≥1.2?mmol/L.

RESULTS: Fewer treated cows were diagnosed with SCK within 12 days post-calving than control cows (144/340 (42.4%) vs. 192/336 (57.1%); p<0.001). There was no interaction between treatment group and age, breed or herd of origin. From the final multivariable model it was estimated that treatment with CRC containing monensin reduced the absolute cumulative incidence of SCK by 17.9 (95% CI=9.2–25.8)% compared to no treatment.

CONCLUSIONS: Treatment with a CRC containing monensin >10 days prior to calving reduced the cumulative incidence of SCK of pasture-based dairy cows in commercial dairy herds within 12 days post-calving.

CLINICAL RELEVANCE: Administration pre-calving of an intra-rumenal bolus containing monensin can be considered as one of a range of management options for the control of SCK in early lactation.